azathioprine and mitoxantrone

azathioprine has been researched along with mitoxantrone in 33 studies

Research

Studies (33)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (6.06)	18.2507
2000's	23 (69.70)	29.6817
2010's	7 (21.21)	24.3611
2020's	1 (3.03)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Schmied, M; Vass, K	1
Rieckmann, P; Toyka, KV	1
Coustans, M; Edan, G	1
Bryant, J; Clegg, A; Milne, R	1
Bryant, J; Clegg, A	1
Freedman, MS; MacLean, HJ	1
Lublin, FD	1
Hommes, OR; Weiner, HL	2
Pender, MP; Wolfe, NP	1
Hartung, HP; Kieseier, BC	1
Hohlfeld, R; Jarius, S; Voltz, R	1
Jeffery, DR	1
Bereczki, D; Csépány, T; Csiba, L; Mezei, Z	1
Stuart, WH	1
Chaperon, J; Coustans, M; Edan, G; Le Page, E; Leray, E; Morrissey, SP; Taurin, G	1
Berthier, F; Clavelou, P; Danzon, A; de Seze, J; Debouverie, M; Defer, G; Gout, O; Lebrun, C; Rumbach, L; Vermersch, P; Wiertlevski, S	1
Benedetti, MD; Invernizzi, P; Monaco, S; Poli, S	1
Gold, R; Hartung, HP; Hohlfeld, R; Rieckmann, P; Toyka, KV; Wiendl, H	1
Saida, T	1
Jung, IJ; Kim, HJ; Kim, SH; Kim, W; Li, XF	1
Graves, D; Vernino, S	1
Karni, A; Kolb, H; Stankiewicz, JM; Weiner, HL	1
Al-Kali, A; Castro, J; Dueck, A; Ertz-Archambault, N; Finn, L; Foran, J; Gauthier, S; Kelemen, K; Kosiorek, H; Marino, R; Mesa, RA; Palmer, J; Sproat, LZ; Taylor, GE; Tibes, R	1
Aktas, O; Angstwurm, K; Berthele, A; Borisow, N; Faiss, J; Fischer, K; Friede, T; Gahlen, A; Geis, C; Hartung, HP; Havla, J; Hellwig, K; Hemmer, B; Hofstadt-van Oy, U; Jarius, S; Kleinschnitz, C; Kleiter, I; Krumbholz, M; Kümpfel, T; Lauda, F; Linker, RA; Marziniak, M; Mayer, C; Neuhaus, O; Pache, F; Paul, F; Ringelstein, M; Ruprecht, K; Schuster, S; Schwab, M; Stangel, M; Stellmann, JP; Then Bergh, F; Trebst, C; Tumani, H; Wildemann, B; Young, KL; Zeltner, L; Zettl, U; Ziemann, U	1
Altincatal, A; Berdofe, A; Centonze, D; de Moor, C; Jung, E; Kim, M; Nagpal, A; Naylor, ML; Popescu, C; Radhakrishnan, M; Rajbhandari, R; Reder, AT; Sandrock, AW; Smirnakis, K	1

Reviews

18 review(s) available for azathioprine and mitoxantrone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Current therapy of multiple sclerosis]. Wiener medizinische Wochenschrift (1946), 1996, Volume: 146, Issue:19-20 Topics: Azathioprine; Cladribine; Cyclophosphamide; Glatiramer Acetate; Humans; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis; Peptides; Plasmapheresis; Randomized Controlled Trials as Topic	1996
Escalating immunotherapy of multiple sclerosis.Austrian-German- Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG]. European neurology, 1999, Volume: 42, Issue:3 Topics: Adjuvants, Immunologic; Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Male; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Peptides; Pulse Therapy, Drug	1999
[Is immunosuppression a future therapeutic strategy for multiple sclerosis?]. Pathologie-biologie, 2000, Volume: 48, Issue:2 Topics: Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Mitoxantrone; Multiple Sclerosis	2000
Disease-modifying drugs for multiple sclerosis: a rapid and systematic review. Health technology assessment (Winchester, England), 2000, Volume: 4, Issue:9 Topics: Adjuvants, Immunologic; Azathioprine; Cladribine; Cost-Benefit Analysis; Cyclophosphamide; Drug Costs; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis; Peptides; Research Design; Technology Assessment, Biomedical; Treatment Outcome	2000
[Escalating immunomodulatory therapy of multiple sclerosis. 1st supplement: December 2000]. Der Nervenarzt, 2001, Volume: 72, Issue:2 Topics: Acute Disease; Adjuvants, Immunologic; Austria; Azathioprine; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Germany; Glatiramer Acetate; Humans; Immunoglobulins; Immunosuppressive Agents; Immunotherapy, Active; Interferon beta-1a; Interferon beta-1b; Interferon Type I; Interferon-beta; Magnetic Resonance Imaging; Male; Mitoxantrone; Multiple Sclerosis, Relapsing-Remitting; Peptides; Plasmapheresis; Randomized Controlled Trials as Topic; Recombinant Proteins	2001
Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness. Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:4 Topics: Azathioprine; Cladribine; Cost-Benefit Analysis; Cyclophosphamide; Drug Costs; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis; Peptides	2001
Immunologic therapy for relapsing-remitting multiple sclerosis. Current neurology and neuroscience reports, 2001, Volume: 1, Issue:3 Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Forecasting; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Longitudinal Studies; Methotrexate; Mitoxantrone; Multiple Sclerosis; Peptides; Plasma Exchange; Plasmapheresis; Steroids; Treatment Outcome	2001
Therapeutic approaches to secondary progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2002, Volume: 8, Issue:1 Topics: Anti-Inflammatory Agents; Azathioprine; Bone Marrow Transplantation; Cladribine; Clinical Trials as Topic; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Methotrexate; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Chronic Progressive	2002
Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects. Internal medicine journal, 2002, Volume: 32, Issue:11 Topics: Adjuvants, Immunologic; Autoimmune Diseases; Azathioprine; B-Lymphocytes; Cyclophosphamide; Disease Progression; Genetic Predisposition to Disease; Glatiramer Acetate; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Interferon-beta; Magnetic Resonance Imaging; Methotrexate; Methylprednisolone; Mitoxantrone; Models, Theoretical; Multiple Sclerosis; Peptides	2002
Current disease-modifying therapies in multiple sclerosis. Seminars in neurology, 2003, Volume: 23, Issue:2 Topics: Adjuvants, Immunologic; Analgesics; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclophosphamide; Cyclosporine; Glatiramer Acetate; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Peptides; Plasma Exchange	2003
[Diagnosis and treatment of multiple sclerosis. Update, 2003]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Acute Disease; Adjuvants, Immunologic; Analgesics; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Controlled Clinical Trials as Topic; Cross-Over Studies; Glatiramer Acetate; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Longitudinal Studies; Methylprednisolone; Mitoxantrone; Multicenter Studies as Topic; Multiple Sclerosis; Natalizumab; Peptides; Pilot Projects; Prospective Studies; Recurrence; Time Factors	2003
Use of combination therapy with immunomodulators and immunosuppressants in treating multiple sclerosis. Neurology, 2004, Dec-28, Volume: 63, Issue:12 Suppl 6 Topics: Azathioprine; Drug Antagonism; Drug Resistance; Drug Therapy, Combination; Humans; Immunologic Factors; Immunosuppressive Agents; Inflammation; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis	2004
Combination therapy for the treatment of multiple sclerosis: challenges and opportunities. Current medical research and opinion, 2007, Volume: 23, Issue:6 Topics: Adrenal Cortex Hormones; Analgesics; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Cytotoxins; Drug Therapy, Combination; Glatiramer Acetate; Humans; Immunosuppressive Agents; Immunotherapy; Methotrexate; Mitoxantrone; Multiple Sclerosis; Peptides	2007
Azathioprine in multiple sclerosis. Mini reviews in medicinal chemistry, 2008, Volume: 8, Issue:9 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Chemistry, Pharmaceutical; Cyclophosphamide; Drug Design; Fingolimod Hydrochloride; Humans; Immunologic Factors; Immunosuppressive Agents; Methotrexate; Methyltransferases; Mitoxantrone; Models, Chemical; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Propylene Glycols; Sphingosine	2008
[Treatment of NMO]. Rinsho shinkeigaku = Clinical neurology, 2009, Volume: 49, Issue:11 Topics: Acute-Phase Reaction; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Humans; Immunosuppressive Agents; Interferon beta-1b; Interferon-beta; Methylprednisolone; Mitoxantrone; Neuromyelitis Optica; Plasma Exchange; Prednisolone; Pulse Therapy, Drug; Recurrence; Rituximab	2009
Immunotherapies in neurologic disorders. The Medical clinics of North America, 2012, Volume: 96, Issue:3 Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Mitoxantrone; Mycophenolic Acid; Natalizumab; Nervous System Diseases; Peptides; Plasma Exchange; Propylene Glycols; Rituximab; Sphingosine; Tacrolimus	2012
Role of immunosuppressive therapy for the treatment of multiple sclerosis. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2013, Volume: 10, Issue:1 Topics: Adult; Azathioprine; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid	2013

Trials

1 trial(s) available for azathioprine and mitoxantrone

Article	Year
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients. Journal of neurology, neurosurgery, and psychiatry, 2008, Volume: 79, Issue:1 Topics: Adult; Antineoplastic Agents; Antiviral Agents; Azathioprine; Brain; Demography; Disability Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Relapsing-Remitting; Observation; Peptides; Prevalence; Recurrence	2008

Article

Year

Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.

Journal of neurology, neurosurgery, and psychiatry, 2008, Volume: 79, Issue:1

Topics: Adult; Antineoplastic Agents; Antiviral Agents; Azathioprine; Brain; Demography; Disability Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Relapsing-Remitting; Observation; Peptides; Prevalence; Recurrence

2008

Other Studies

14 other study(ies) available for azathioprine and mitoxantrone

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nature chemical biology, 2009, Volume: 5, Issue:10 Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Results of an international questionnaire on immunosuppressive treatment of multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2002, Volume: 8, Issue:2 Topics: Azathioprine; Canada; Cyclophosphamide; Drug Utilization; Europe; Health Facilities; Humans; Immunosuppressive Agents; International Cooperation; Methotrexate; Mitoxantrone; Multiple Sclerosis; Pilot Projects; Surveys and Questionnaires; United States	2002
Clinical practice of immunosuppressive treatments in multiple sclerosis: results of a second international questionnaire. Journal of the neurological sciences, 2004, Aug-15, Volume: 223, Issue:1 Topics: Azathioprine; Canada; Clinical Trials as Topic; Cyclophosphamide; Europe; Humans; Immunosuppressive Agents; Immunotherapy; International Cooperation; Methotrexate; Mitoxantrone; Multiple Sclerosis; Practice Patterns, Physicians'; Scandinavian and Nordic Countries; South America; Surveys and Questionnaires; United Kingdom; United States	2004
[Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary]. Ideggyogyaszati szemle, 2006, Nov-20, Volume: 59, Issue:11-12 Topics: Adult; Arm; Azathioprine; Cognition; Disability Evaluation; Female; Glatiramer Acetate; Hand Strength; Humans; Hungary; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Leg; Male; Middle Aged; Mitoxantrone; Multiple Sclerosis, Relapsing-Remitting; Peptides; Prospective Studies; Walking	2006
Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2008, Volume: 14, Issue:3 Topics: Adult; Azathioprine; Breast Neoplasms; Central Nervous System Neoplasms; Cyclophosphamide; Digestive System Neoplasms; Female; Genital Neoplasms, Female; Glatiramer Acetate; Humans; Immunosuppressive Agents; Incidence; Interferon-beta; Leukemia; Lymphoma; Male; Middle Aged; Mitoxantrone; Multiple Sclerosis; Neoplasms; Peptides; Registries; Risk Factors; Skin Neoplasms; Urologic Neoplasms	2008
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations. Journal of neurology, 2008, Volume: 255, Issue:10 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Europe; Glatiramer Acetate; Health Planning Guidelines; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Interferon-beta; Magnetic Resonance Imaging; Mitoxantrone; Multiple Sclerosis; Natalizumab; Peptides; Plasmapheresis; Randomized Controlled Trials as Topic; Societies	2008
Clinical spectrum of CNS aquaporin-4 autoimmunity. Neurology, 2012, Apr-10, Volume: 78, Issue:15 Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Aquaporin 4; Autoantibodies; Autoimmunity; Azathioprine; Disabled Persons; Drug Administration Schedule; Early Diagnosis; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Interferon-beta; Kaplan-Meier Estimate; Male; Middle Aged; Mitoxantrone; Multivariate Analysis; Mycophenolic Acid; Neuromyelitis Optica; Predictive Value of Tests; Prednisolone; Prognosis; Republic of Korea; Rituximab	2012
Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia. JAMA oncology, 2017, Jul-01, Volume: 3, Issue:7 Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Case-Control Studies; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myeloid, Acute; Lupus Erythematosus, Systemic; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Mycophenolic Acid; Myelodysplastic Syndromes; Odds Ratio; Psoriasis; Retrospective Studies; Risk Factors; United States	2017
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response. Journal of neurology, neurosurgery, and psychiatry, 2017, Volume: 88, Issue:8 Topics: Adult; Aquaporin 4; Autoantibodies; Azathioprine; Cohort Studies; Female; Follow-Up Studies; Germany; Glatiramer Acetate; Humans; Immunotherapy; Interferon-beta; Long-Term Care; Male; Middle Aged; Mitoxantrone; Neuromyelitis Optica; Prognosis; Recurrence; Registries; Retrospective Studies; Rituximab; Treatment Outcome	2017
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies. CNS drugs, 2021, Volume: 35, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cladribine; Comorbidity; COVID-19; Crotonates; Cyclophosphamide; Cyclosporine; Databases, Factual; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hospitalization; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Incidence; Interferon-beta; Logistic Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid; Natalizumab; Nitriles; Obesity; Risk Factors; Rituximab; SARS-CoV-2; Toluidines; United States; White People; Young Adult	2021